Inhibiting Breast Cancer Progression by Exploiting TGFβ Signaling

被引：1

作者：

Baxley, Sarah E. ^{[1
]}

Serra, Rosa ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA

来源：

CURRENT DRUG TARGETS | 2010年 / 11卷 / 09期

关键词：

Apoptosis; breast cancer; cytostatic; immune regulation; metastasis; stem cell; TGF beta; TRANSFORMING-GROWTH-FACTOR; MAMMARY EPITHELIAL-CELLS; RECEPTOR-TYPE-I; ACTIVATED PROTEIN-KINASES; ACUTE MYELOID-LEUKEMIA; STEM-CELLS; MESENCHYMAL TRANSITION; PHOSPHATIDYLINOSITOL; 3-KINASE; TUMOR-GROWTH; TRANSFORMING-GROWTH-FACTOR-BETA-1; GENE;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Transforming Growth Factor beta (TGF beta) signaling influences most aspects of cellular function in addition to playing a major role in organ development, remodeling, and repair. Given the wide range of effects induced by TGF beta, it is not surprising that alterations in TGF beta signaling have been implicated in development and progression of many different cancer types. Within the context of breast cancer itself, TGF beta is known to have a dual nature, being both tumor-suppressive during early breast cancer development and tumor-promoting during breast cancer metastasis. Targets for breast cancer therapeutics are greatly needed to decrease morbidity and mortality from this devastating disease. Here, we summarize what is known about TGF beta in breast cancer progression and discuss potential TGF beta targets for breast cancer therapeutics.

引用

页码：1089 / 1102

页数：14

共 174 条

[1] A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis [J].

Adorno, Maddalena ;

Cordenonsi, Michelangelo ;

Montagner, Marco ;

Dupont, Sirio ;

Wong, Christine ;

Hann, Byron ;

Solari, Aldo ;

Bobisse, Sara ;

Rondina, Maria Beatrice ;

Guzzardo, Vincenza ;

Parenti, Anna R. ;

Rosato, Antonio ;

Bicciato, Silvio ;

Balmain, Allan ;

Piccolo, Stefano .

CELL, 2009, 137 (01) :87-98

[2] Prospective identification of tumorigenic breast cancer cells [J].

Al-Hajj, M ;

Wicha, MS ;

Benito-Hernandez, A ;

Morrison, SJ ;

Clarke, MF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988

[3]

ALEXANDROW MG, 1995, CANCER RES, V55, P1452

[4] Making sense of latent TGFβ activation [J].

Annes, JP ;

Munger, JS ;

Rifkin, DB .

JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224

[5]

ARTEAGA CL, 1993, CELL GROWTH DIFFER, V4, P193

[6] Prolactin and transforming growth factor-β signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway [J].

Bailey, JP ;

Nieport, KM ;

Herbst, MP ;

Srivastava, S ;

Serra, RA ;

Horseman, ND .

MOLECULAR ENDOCRINOLOGY, 2004, 18 (05) :1171-1184

[7] Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration [J].

Bakin, AV ;

Tomlinson, AK ;

Bhowmick, NA ;

Moses, HL ;

Arteaga, CL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36803-36810

[8]

Bandyopadhyay A, 1999, CANCER RES, V59, P5041

[9]

Bandyopadhyay A, 2002, CANCER RES, V62, P4690

[10] Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cells [J].

Bandyopadhyay, A ;

Zhu, Y ;

Malik, SN ;

Kreisberg, J ;

Brattain, MG ;

Sprague, EA ;

Luo, J ;

López-Casillas, F ;

Sun, LZ .

ONCOGENE, 2002, 21 (22) :3541-3551

← 1 2 3 4 5 6 7 8 9 10 →